ES2036396T3 - Solucion acuosa de folinato estable a la temperatura del refrigerador asi como proceso para su preparacion. - Google Patents

Solucion acuosa de folinato estable a la temperatura del refrigerador asi como proceso para su preparacion.

Info

Publication number
ES2036396T3
ES2036396T3 ES199090201353T ES90201353T ES2036396T3 ES 2036396 T3 ES2036396 T3 ES 2036396T3 ES 199090201353 T ES199090201353 T ES 199090201353T ES 90201353 T ES90201353 T ES 90201353T ES 2036396 T3 ES2036396 T3 ES 2036396T3
Authority
ES
Spain
Prior art keywords
folinate
well
stable
refrigerator
temperature
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES199090201353T
Other languages
English (en)
Inventor
Alfred James Nijker
Johanna Maria Pieternella Vermeer
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pharmachemie BV
Original Assignee
Pharmachemie BV
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharmachemie BV filed Critical Pharmachemie BV
Application granted granted Critical
Publication of ES2036396T3 publication Critical patent/ES2036396T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A61K47/183—Amino acids, e.g. glycine, EDTA or aspartame

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Preventing Corrosion Or Incrustation Of Metals (AREA)
  • Medicinal Preparation (AREA)

Abstract

SE PROPORCIONA UNA SOLUCION ACUOSA DE FOLINATO ESTABLE, QUE CONTIENE IONES DE FOLINATO, IONES DE CALCIO COMPLEJOS, Y SI SE DESEA, IONES DE CALCIO LIBRES, EN UNA CANTIDAD TOTAL DE MAS DE 12 MG/ML. TAMBIEN SE PROPORCIONAN LOS ANIONES DE UN AGENTE COMPLEXANTE DEL CALCIO. LA SOLUCION ES PREPARADA MEDIANTE LA INCORPORACION DE DICHO AGENTE A LA MISMA.
ES199090201353T 1989-06-06 1990-05-28 Solucion acuosa de folinato estable a la temperatura del refrigerador asi como proceso para su preparacion. Expired - Lifetime ES2036396T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
NL8901432A NL8901432A (nl) 1989-06-06 1989-06-06 Bij koelkasttemperatuur stabiele waterige folinaatoplossing, alsmede werkwijze ter bereiding daarvan.

Publications (1)

Publication Number Publication Date
ES2036396T3 true ES2036396T3 (es) 1993-05-16

Family

ID=19854784

Family Applications (1)

Application Number Title Priority Date Filing Date
ES199090201353T Expired - Lifetime ES2036396T3 (es) 1989-06-06 1990-05-28 Solucion acuosa de folinato estable a la temperatura del refrigerador asi como proceso para su preparacion.

Country Status (13)

Country Link
US (1) US5177076A (es)
EP (1) EP0401895B1 (es)
JP (1) JP2945718B2 (es)
AT (1) ATE83660T1 (es)
AU (1) AU626421B2 (es)
CA (1) CA2018230C (es)
DE (1) DE69000645T2 (es)
DK (1) DK0401895T3 (es)
ES (1) ES2036396T3 (es)
FI (1) FI96275C (es)
IL (1) IL92370A0 (es)
NL (1) NL8901432A (es)
NO (1) NO176389C (es)

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH684644A5 (de) 1992-07-13 1994-11-15 Eprova Ag 5,10-Methylentetrahydrofolsäure-Cyclodextrin-Einschlussverbindungen.
KR100188318B1 (ko) * 1993-04-28 1999-06-01 고오야 마사시 안정화된 주사제 및 주사제의 안정화법
CH687062A5 (de) * 1994-02-14 1996-09-13 Cerbios Pharma Sa Konzentrierte Injektionsloesung von Alkalimetallsalzen von reduzierten Folaten.
NL9400530A (nl) * 1994-04-05 1995-11-01 Pharmachemie Bv Stabiele waterige folinaatoplossing.
US5660835A (en) * 1995-02-24 1997-08-26 East Carolina University Method of treating adenosine depletion
US20020032160A1 (en) * 1995-02-24 2002-03-14 Nyce Jonathan W. Compositions & formulations with an epiandrosterone or a ubiquinone & kits & their use for treatment of asthma symptoms & for reducing adenosine/adenosine receptor levels
US5980882A (en) * 1997-04-16 1999-11-09 Medeva Pharmaceuticals Manufacturing Drug-resin complexes stabilized by chelating agents
WO2002085297A2 (en) * 2001-04-24 2002-10-31 East Carolina University Compositions & formulations with a non-glucocorticoid steroid &/or a ubiquinone & kit for treatment of respiratory & lung disease
WO2002085296A2 (en) * 2001-04-24 2002-10-31 Epigenesis Pharmaceuticals, Inc. Composition, formulations and kit for treatment of respiratory and lung disease with non-glucocorticoid steroids and/or ubiquinone and a bronchodilating agent
US7405207B2 (en) * 2002-06-17 2008-07-29 Epigenesis Pharmaceuticals, Inc. Nebulizer formulations of dehydroepiandrosterone and methods of treating asthma or chronic obstructive pulmonary disease using compositions thereof
AU2003269889B2 (en) * 2002-06-17 2007-04-19 Epigenesis Pharmaceuticals, Llc Dihydrate dehydroepiandrosterone and methods of treating asthma or chronic obstructive pulmonary disease using compositions thereof
US20050038004A1 (en) * 2003-07-31 2005-02-17 Robinson Cynthia B. Combination of dehydroepiandrosterone or dehydroepiandrosterone-sulfate with an anticholinergic bronchodilator for treatment of asthma or chronic obstructive pulmonary disease
US20050026848A1 (en) * 2003-07-31 2005-02-03 Robinson Cynthia B. Combination of dehydroepiandrosterone or dehydroepiandrosterone-sulfate with a methylxanthine derivative for treatment of asthma or chronic obstructive pulmonary disease
US20090297611A1 (en) * 2003-07-31 2009-12-03 Robinson Cynthia B Combination of dehydroepiandrosterone or dehydroepiandrosterone-sulfate with a tyrosine kinase inhibitor, delta opioid receptor antagonist, neurokinin receptor antagonist, or vcam inhibitor for treatment of asthma or chronic obstructive pulmonary disease
US20050101545A1 (en) * 2003-07-31 2005-05-12 Robinson Cynthia B. Combination of dehydroepiandrosterone or dehydroepiandrosterone-sulfate with an anticholinergic bronchodilator for treatment of asthma or chronic obstructive pulmonary disease
US20050085430A1 (en) * 2003-07-31 2005-04-21 Robinson Cynthia B. Combination of dehydroepiandrosterone or dehydroepiandrosterone-sulfate with a PDE-4 inhibitor for treatment of asthma or chronic obstructive pulmonary disease
US20050043282A1 (en) * 2003-07-31 2005-02-24 Robinson Cynthia B. Combination of dehydroepiandrosterone or dehydroepiandrosterone-sulfate with a lipoxygenase inhibitor for treatment of asthma or chronic obstructive pulmonary disease
US20050026881A1 (en) * 2003-07-31 2005-02-03 Robinson Cynthia B. Combination of dehydroepiandrosterone or dehydroepiandrosterone-sulfate with an anti-IgE antibody for treatment of asthma or chronic obstructive pulmonary disease
US20050026879A1 (en) * 2003-07-31 2005-02-03 Robinson Cynthia B. Combination of dehydroepiandrosterone or dehydroepiandrosterone-sulfate with a tyrosine kinase inhibitor, delta opioid receptor antagonist, neurokinin receptor antagonist, or VCAM inhibitor for treatment of asthma or chronic obstructive pulmonary disease
US20090285899A1 (en) * 2003-07-31 2009-11-19 Robinson Cynthia B Combination of dehydroepiandrosterone or dehydroepiandrosterone-sulfate with a methylxanthine derivative for treatment of asthma or chronic obstructive pulmonary disease
US20090263381A1 (en) * 2003-07-31 2009-10-22 Robinson Cynthia B Combination of dehydroepiandrosterone or dehydroepiandrosterone-sulfate with an anti-ige antibody for treatment of asthma or chronic obstructive pulmonary disease
US20050026884A1 (en) * 2003-07-31 2005-02-03 Robinson Cynthia B. Combination of dehydroepiandrosterone or dehydroepiandrosterone-sulfate with a beta-agonist bronchodilator for treatment of asthma or chronic obstructive pulmonary disease
US20050113318A1 (en) * 2003-07-31 2005-05-26 Robinson Cynthia B. Combination of dehydroepiandrosterone or dehydroepiandrosterone-sulfate with a beta-agonist bronchodilator for treatment of asthma or chronic obstructive pulmonary disease
US20050026880A1 (en) * 2003-07-31 2005-02-03 Robinson Cynthia B. Combination of dehydroepiandrosterone or dehydroepiandrosterone-sulfate with a cromone for treatment of asthma or chronic obstructive pulmonary disease
US20050026890A1 (en) * 2003-07-31 2005-02-03 Robinson Cynthia B. Combination of dehydroepiandrosterone or dehydroepiandrosterone-sulfate with an antihistamine for treatment of asthma or chronic obstructive pulmonary disease
US20090285900A1 (en) * 2003-07-31 2009-11-19 Robinson Cynthia B Combination of dehydroepiandrosterone or dehydroepiandrosterone-sulfate with a beta-agonist bronchodilator for treatment of asthma or chronic obstructive pulmonary disease
US20050026883A1 (en) * 2003-07-31 2005-02-03 Robinson Cynthia B. Combination of dehydroepiandrosterone or dehydroepiandrosterone-sulfate with a PDE-4 inhibitor for treatment of asthma or chronic obstructive pulmonary disease
US20050026882A1 (en) * 2003-07-31 2005-02-03 Robinson Cynthia B. Combination of dehydroepiandrosterone or dehydroepiandrosterone-sulfate with a leukotriene receptor antagonist for treatment of asthma or chronic obstructive pulmonary disease
US20090274676A1 (en) * 2003-07-31 2009-11-05 Robinson Cynthia B Combination of dehydroepiandrosterone or dehydroepiandrosterone-sulfate with a pde-4 inhibitor for treatment of asthma or chronic obstructive pulmonary disease
CH696717A5 (de) * 2004-02-20 2007-10-31 Cerbios Pharma Sa Konzentrierte, stabile Losung, insbesondere eine Injektionslosung oder Infusionslosung, welche nebst Wasser entweder (6S)-Natrium-Folinat oder (6S)-Kalium-Folinat entholt
KR20060051135A (ko) * 2004-09-15 2006-05-19 니프로 가부시키가이샤 안정화된 주사용 수용액 제재
US9713616B2 (en) 2012-08-06 2017-07-25 Spectrum Pharmaceuticals, Inc. Pharmaceutical compositions comprising L-leucovorin
CN120617167B (zh) * 2025-07-25 2026-03-24 连云港众维生物医药有限公司 提高亚叶酸钙注射液稳定性非最终灭菌生产工艺及应用

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2695860A (en) * 1952-04-29 1954-11-30 American Cyanamid Co Stabilized pteroyl solutions
GB1572137A (en) * 1977-02-22 1980-07-23 Bioresearch Sas Del Dr Livio C Stable compositions for therapeutic use based on d,1-5-methyltetrahydrofolic acid and its salts
US4344940A (en) * 1981-11-30 1982-08-17 E. R. Squibb & Sons, Inc. Steroid formulation containing dipotassium EDTA
US4436738A (en) * 1982-03-15 1984-03-13 Mead Johnson & Company Stabilized estradiol cream composition

Also Published As

Publication number Publication date
DE69000645D1 (de) 1993-02-04
FI902712A0 (fi) 1990-05-31
EP0401895A1 (en) 1990-12-12
US5177076A (en) 1993-01-05
NO176389C (no) 1995-03-29
FI96275C (fi) 1996-06-10
JPH0356418A (ja) 1991-03-12
DK0401895T3 (da) 1993-04-13
NL8901432A (nl) 1991-01-02
DE69000645T2 (de) 1993-05-13
AU626421B2 (en) 1992-07-30
CA2018230C (en) 1996-04-16
NO902487L (no) 1990-12-07
CA2018230A1 (en) 1990-12-06
NO176389B (no) 1994-12-19
FI96275B (fi) 1996-02-29
IL92370A0 (en) 1990-07-26
EP0401895B1 (en) 1992-12-23
JP2945718B2 (ja) 1999-09-06
AU5629790A (en) 1990-12-13
NO902487D0 (no) 1990-06-05
ATE83660T1 (de) 1993-01-15

Similar Documents

Publication Publication Date Title
FI902712A0 (fi) Menetelmä stabiilin vesipitoisen kalsiumfolinaattiliuoksen valmistamiseksi
ATE158918T1 (de) Konservierungslösung für zellen
DE3567463D1 (en) 4-dimethylamino-1-hydroxybutane-1,1-diphosphonic acid, its water soluble salts, process for their preparation and its use
ATE104983T1 (de) Avermectin-ketal-derivate, die als antiparasitenmittel geeignet sind.
GB2316006A (en) Stomach-action molluscicides
ES2093791T3 (es) Composiciones desinfectantes esporicidas, produccion y uso de las mismas.
EP0147464A4 (en) CHEMICALLY ACTIVE AQUEOUS SOLUTION AND SOLID SUBSTANCE CONTAINING FERROUS IONS.
MY130555A (en) Super absorbent polymer composition
HU912649D0 (en) New tricyclic compounds production threreof and anti-microbic preparatives
GR3006426T3 (es)
ATE141919T1 (de) Methode um methylol-hydantoine mit niedriger konzentration an freiem formaldehyd, herstellung und deren zusammensetzungen
ES2028277T3 (es) Sintesis de zeolita l.
ES456359A1 (es) Procedimiento para preparar derivados de n-trocloroacetil- n'-clorobenzoilhidrazina.
KR840008285A (ko) 표준화한 요오도퍼 제제(Iodophor 製劑)와 그의 제조방법
CA2101554A1 (en) Solubility compound fertilizer compositions
DE3264314D1 (en) Fungicidal agent
ES8603506A1 (es) Un procedimiento para la preparacion de 9-deoxo-9a-metil-9a-aza-9a-homoeritromicina b o una sal de la misma
ES8106536A1 (es) Procedimiento de preparacion de nuevos derivados ergol-8- enos y ergolinos y de sus sales de adicion acidas
GR3033863T3 (en) Stable aqueous folinate solution
NZ219284A (en) Fluoboric acid salt of n-tridecyl-2,6-dimethylmorpholine and pesticidal compositions
Chouhan et al. On the tolerance limits and toxicity symptoms of guppy(Lebistes reticulatus) to fertilizers: Urea and ammonium sulphate.
IL61014A (en) Manufacture of 4-amino-5-chloro-1-phenylpyridaz-6-one
ES8702304A1 (es) Procedimiento para fabricar carbonato de sodio anhidro denso
ZA891077B (en) Process for the preparation of 1,2-disulfone compounds
SE9202434D0 (sv) Skatolinaktiverande komposition

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 401895

Country of ref document: ES